These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 38454300)
1. Movement Disorder Perspectives on Monocarboxylate 8 Deficiency: A Case Series of 3 Colombian Patients with Allan-Herndon-Dudley Syndrome. Ramon-Gomez JL; Cortés-Rojas MC; Polania-Puentes MJ; Guerrero-Ruiz GDP Mov Disord Clin Pract; 2024 May; 11(5):567-570. PubMed ID: 38454300 [TBL] [Abstract][Full Text] [Related]
2. Myelination Delay and Allan-Herndon-Dudley Syndrome Caused by a Novel Mutation in the SLC16A2 Gene. La Piana R; Vanasse M; Brais B; Bernard G J Child Neurol; 2015 Sep; 30(10):1371-4. PubMed ID: 25380603 [TBL] [Abstract][Full Text] [Related]
3. Expanding the phenotypic spectrum of Allan-Herndon-Dudley syndrome in patients with SLC16A2 mutations. Remerand G; Boespflug-Tanguy O; Tonduti D; Touraine R; Rodriguez D; Curie A; Perreton N; Des Portes V; Sarret C; Dev Med Child Neurol; 2019 Dec; 61(12):1439-1447. PubMed ID: 31410843 [TBL] [Abstract][Full Text] [Related]
4. A novel variant in SLC16A2 associated with typical Allan-Herndon-Dudley syndrome: a case report. Chen X; Liu L; Zeng C BMC Pediatr; 2022 Apr; 22(1):180. PubMed ID: 35382784 [TBL] [Abstract][Full Text] [Related]
6. [The importance of thyroid hormone transporters]. Braun D Nuklearmedizin; 2015; 54(3):77-81. PubMed ID: 26105714 [TBL] [Abstract][Full Text] [Related]
7. Allan-Herndon-Dudley syndrome (AHDS) in two consecutive generations caused by a missense MCT8 gene mutation. Phenotypic variability with the presence of normal serum T3 levels. Boccone L; Dessì V; Meloni A; Loudianos G Eur J Med Genet; 2013 Apr; 56(4):207-10. PubMed ID: 23419639 [TBL] [Abstract][Full Text] [Related]
8. First female with Allan-Herndon-Dudley syndrome and partial deletion of X-inactivation center. Quesada-Espinosa JF; Garzón-Lorenzo L; Lezana-Rosales JM; Gómez-Rodríguez MJ; Sánchez-Calvin MT; Palma-Milla C; Gómez-Manjón I; Hidalgo-Mayoral I; Pérez de la Fuente R; Arteche-López A; Álvarez-Mora MI; Camacho-Salas A; Cruz-Rojo J; Lázaro-Rodríguez I; Morales-Conejo M; Nuñez-Enamorado N; Bustamante-Aragones A; Simón de Las Heras R; Gomez-Cano MA; Ramos-Gómez P; Sierra-Tomillo O; Juárez-Rufián A; Gallego-Merlo J; Rausell-Sánchez L; Moreno-García M; Sánchez Del Pozo J Neurogenetics; 2021 Oct; 22(4):343-346. PubMed ID: 34296368 [TBL] [Abstract][Full Text] [Related]
9. [A family with Allan-Herndon-Dudley syndrome due to SLC16A2 gene mutation]. Tang YL; Peng J; Xiong J; Pang N; Wu LW; Yang HY; Kessi M; Yin F Zhonghua Er Ke Za Zhi; 2018 Nov; 56(11):829-834. PubMed ID: 30392207 [No Abstract] [Full Text] [Related]
11. Variable Clinical Characteristics and Molecular Spectrum of Patients with Syndromes of Reduced Sensitivity to Thyroid Hormone: Genetic Defects in the THRB and SLC16A2 Genes. Choi JH; Cho JH; Kim JH; Yoo EG; Kim GH; Yoo HW Horm Res Paediatr; 2018; 90(5):283-290. PubMed ID: 30497070 [TBL] [Abstract][Full Text] [Related]
12. Delayed myelination is not a constant feature of Allan-Herndon-Dudley syndrome: report of a new case and review of the literature. Azzolini S; Nosadini M; Balzarin M; Sartori S; Suppiej A; Mardari R; Greggio NA; Toldo I Brain Dev; 2014 Sep; 36(8):716-20. PubMed ID: 24268987 [TBL] [Abstract][Full Text] [Related]
13. Clinical and endocrine features of two Allan-Herndon-Dudley syndrome patients with monocarboxylate transporter 8 mutations. Kim JH; Kim YM; Yum MS; Choi JH; Lee BH; Kim GH; Yoo HW Horm Res Paediatr; 2015; 83(4):288-92. PubMed ID: 25896225 [TBL] [Abstract][Full Text] [Related]
14. Clinical course and images of four familial cases of Allan-Herndon-Dudley syndrome with a novel monocarboxylate transporter 8 gene mutation. Kobayashi S; Onuma A; Inui T; Wakusawa K; Tanaka S; Shimojima K; Yamamoto T; Haginoya K Pediatr Neurol; 2014 Sep; 51(3):414-6. PubMed ID: 25160547 [TBL] [Abstract][Full Text] [Related]
15. Late diagnosis of the X-linked MCT8 deficiency (Allan-Herndon-Dudley syndrome) in a teenage girl with primary ovarian insufficiency. Sriram S; Shahid N; Mysliwiec D D; Lichter-Konecki U; Yatsenko SA; Garibaldi LR J Pediatr Endocrinol Metab; 2024 Apr; 37(4):371-374. PubMed ID: 38345890 [TBL] [Abstract][Full Text] [Related]
16. Clinical and Molecular Characteristics of SLC16A2 (MCT8) Mutations in Three Families with the Allan-Herndon-Dudley Syndrome. Novara F; Groeneweg S; Freri E; Estienne M; Reho P; Matricardi S; Castellotti B; Visser WE; Zuffardi O; Visser TJ Hum Mutat; 2017 Mar; 38(3):260-264. PubMed ID: 27805744 [TBL] [Abstract][Full Text] [Related]
17. Identification of a novel nonsense SLC16A2 gene mutation in an infant with severe neurologic phenotype: A case report. Peng W; Shi S; Yang L; Liu D Medicine (Baltimore); 2024 Jul; 103(29):e39047. PubMed ID: 39029020 [TBL] [Abstract][Full Text] [Related]
18. Functional analysis of monocarboxylate transporter 8 mutations in Japanese Allan-Herndon-Dudley syndrome patients. Islam MS; Namba N; Ohata Y; Fujiwara M; Nakano C; Takeyari S; Miyata K; Nakano Y; Yamamoto K; Nakayama H; Kitaoka T; Kubota T; Ozono K Endocr J; 2019 Jan; 66(1):19-29. PubMed ID: 30369548 [TBL] [Abstract][Full Text] [Related]
19. [Clinical and genetic features of five patients with Allan-Herndon-Dudley syndrome]. Wang J; Zhang Q; Bao X; Chen Y; Yu S Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2018 Aug; 35(4):484-488. PubMed ID: 30098239 [TBL] [Abstract][Full Text] [Related]
20. Allan-Herndon-Dudley syndrome (AHDS) caused by a novel SLC16A2 gene mutation showing severe neurologic features and unexpectedly low TRH-stimulated serum TSH. Boccone L; Mariotti S; Dessì V; Pruna D; Meloni A; Loudianos G Eur J Med Genet; 2010; 53(6):392-5. PubMed ID: 20713192 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]